Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trialCatherine Thiéblemont, Pieternella J. Lugtenburg, Hervé Ghesquières et al.|Leukemia|2024Cited by 132